The present invention mainly relates to a vapor fraction from seeds of Glycine max (L.) Merr. prepared by vaporizing a rude extract, and pharmaceutical composition thereof. The present invention also provides the use of the vapor fraction in treating skin injuries, dermatological disorders, stimulating cell regeneration, and stimulating hair growth.